(ZBH) Zimmer Biomet Holdings - Ratings and Ratios

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is a global medical technology leader specializing in orthopedic reconstruction, sports medicine, biologics, and extremities. Since its founding in 1927, the company has established itself as a pioneer in musculoskeletal healthcare, offering a comprehensive portfolio of products and solutions designed to address bone, joint, and soft tissue disorders. Its product range includes knee and hip replacement systems, trauma solutions, craniomaxillofacial reconstruction products, and advanced surgical technologies. The company serves a diverse customer base, including orthopedic and neurosurgeons, hospitals, and healthcare distributors. Headquartered in Warsaw, Indiana, Zimmer Biomet operates a global network of manufacturing and distribution facilities, ensuring widespread access to its innovative medical solutions.

The companys product lineup includes cutting-edge technologies such as the Rosa Knee System for robotic-assisted knee replacements and the Identity Shoulder System for anatomic shoulder reconstruction. Its biologics portfolio features products like the Trabecular Metal Material, which promotes bone ingrowth and regeneration. Zimmer Biomet also offers a range of digital health solutions, including the ZBEdge AI platform, to enhance surgical planning and outcomes. These advancements underscore the companys commitment to improving patient care and surgical efficiency.

Zimmer Biomets strategic focus on innovation and R&D has positioned it as a key player in the orthopedic devices market. Its acquisition of Biomet in 2015 expanded its capabilities in trauma, extremities, and craniomaxillofacial surgery. The company continues to invest in emerging technologies, such as robotics and artificial intelligence, to maintain its competitive edge. With a strong track record of delivering high-quality medical solutions, Zimmer Biomet remains a trusted partner for healthcare professionals worldwide.

Ticker Symbol: ZBH Exchange: NYSE Type: common stock Country Origin: United States GICS Sub Industry: Health Care Equipment Average Volume 20d: 2080015 Last Price: 96.17 SMA 20: 105.97 SMA 50: 105.60 SMA 200: 107.11 ATR: 3.30 Market Cap: 19372.59M USD P/E: 22.10 P/E Forward: 11.89 P/B: 1.55 P/S: 2.52 RoE: 6.26 3-Month Forecast: - Technical Outlook: ZBH is currently trading below its 20, 50, and 200-day moving averages, indicating potential short-term weakness. The stock may face resistance near $105.60 (SMA 50) and $107.11 (SMA 200). Support levels could be tested around $92.87 (current ATR of 3.30 below the last price of $96.17). - Fundamental Outlook: With a forward P/E of 11.89, ZBH may offer value for long-term investors despite its current high trailing P/E of 22.10. The companys market cap of $19.37B reflects its established position in the healthcare equipment sector. However, the P/B ratio of 1.55 and P/S of 2.52 suggest moderate valuation levels.